Overview

The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
To prescribe oral domperidone for patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy.
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Domperidone